Home  >  Products  >  GRINL1A (glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A ) Blocking Peptide (the C terminal of GRINL1A)(100ug)
GRINL1A (glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A ) Blocking Peptide (the C terminal of GRINL1A)(100ug)

GRINL1A (glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A ) Blocking Peptide (the C terminal of GRINL1A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GRINL1A Antibody (ARP62222_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62222
Size: 100ug
Weight: 40kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene (GRINL1A) is part of a complex transcript unit that includes the gene for GRINL1A combined protein (Gcom1). Transcription of this gene occurs at a downstream promoter, with at least three different alternatively spliced variants, grouped together as Gdown for GRINL1A downstream transcripts. The Gcom1 gene uses an upstream promoter for transcription and also has multiple alternatively spliced variants.
Alternative names: DKFZp586F1918
See Full Product Listings >